PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+9.65%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.48B
AUM Growth
+$17.8M
(+0.72%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
64.83%
Holding
157
New
15
Increased
31
Reduced
63
Closed
18
Top Buys
| 1 |
Broadcom
AVGO
|
$135M |
| 2 |
ZTO Express
ZTO
|
$65.8M |
| 3 |
TransUnion
TRU
|
$16.5M |
| 4 |
Mobileye
MBLY
|
$15.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$4.92M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$81.8M |
| 2 |
Suzano
SUZ
|
$35.5M |
| 3 |
IDEAYA Biosciences
IDYA
|
$21.9M |
| 4 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
$21.8M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$21.3M |
Sector Composition
| 1 | Technology | 19.71% |
| 2 | Energy | 16.06% |
| 3 | Consumer Discretionary | 15.49% |
| 4 | Industrials | 14.8% |
| 5 | Financials | 14.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Wave Life Sciences
WVE
$1.27B
| $3.7M | 0.15% |
600,155
-55,176
| -8% | -$340K |
|
52
Microsoft
MSFT
$3.76T
| $3.61M | 0.15% |
8,589
-17,400
| -67% | -$7.32M |
|
53
Zoetis
ZTS
$67.6B
| $3.38M | 0.14% |
+20,000
| New | +$3.38M |
|
54
Structure Therapeutics
GPCR
$1.14B
| $3.3M | 0.13% |
77,093
| – | – |
|
55
AC Immune
ACIU
$227M
| $3.24M | 0.13% |
1,095,026
-420,559
| -28% | -$1.24M |
|
|
OMGA
56
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $3.24M | 0.13% |
886,782
| – | – |
|
57
Veeva Systems
VEEV
$44.4B
| $3.15M | 0.13% |
13,614
-1,321
| -9% | -$306K |
|
58
Immatics
IMTX
$662M
| $3.03M | 0.12% |
288,689
-24,885
| -8% | -$262K |
|
59
908 Devices
MASS
$214M
| $2.81M | 0.11% |
372,300
-409,571
| -52% | -$3.09M |
|
60
TORM
TRMD
$2.21B
| $2.79M | 0.11% |
79,825
| – | – |
|
61
Arrowhead Research
ARWR
$3.84B
| $2.78M | 0.11% |
97,168
| – | – |
|
|
LBPH
62
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.74M | 0.11% |
127,048
| – | – |
|
63
lululemon athletica
LULU
$23.8B
| $2.73M | 0.11% |
+7,000
| New | +$2.73M |
|
64
Oracle
ORCL
$628B
| $2.73M | 0.11% |
21,762
-2,381
| -10% | -$299K |
|
65
Lam Research
LRCX
$124B
| $2.63M | 0.11% |
27,050
-100,910
| -79% | -$9.8M |
|
66
Applied Materials
AMAT
$124B
| $2.6M | 0.1% |
12,616
-2,239
| -15% | -$462K |
|
67
Moderna
MRNA
$9.36B
| $2.51M | 0.1% |
23,573
-57,679
| -71% | -$6.15M |
|
68
Keros Therapeutics
KROS
$638M
| $2.3M | 0.09% |
34,715
-14,168
| -29% | -$938K |
|
69
Autodesk
ADSK
$67.6B
| $2.02M | 0.08% |
+7,769
| New | +$2.02M |
|
70
Alpha Teknova
TKNO
$227M
| $1.93M | 0.08% |
727,761
-8,779
| -1% | -$23.3K |
|
71
CureVac
CVAC
$1.21B
| $1.9M | 0.08% |
626,684
+128,778
| +26% | +$390K |
|
72
Q32 Bio
QTTB
$20.9M
| $1.87M | 0.08% |
+109,964
| New | +$1.87M |
|
73
HUTCHMED
HCM
$2.62B
| $1.85M | 0.07% |
110,366
-16,972
| -13% | -$285K |
|
74
NXP Semiconductors
NXPI
$57.5B
| $1.7M | 0.07% |
6,866
-725
| -10% | -$180K |
|
75
Bio-Techne
TECH
$8.3B
| $1.61M | 0.06% |
+22,824
| New | +$1.61M |
|